We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
19/1/2017 22:39 | Finncap have already fired a shot across the bows of the MMs for a vicious mark down for someone needing stock before, so hopefully if a sizeable lump is needed again they may be able to facilitate. Evans 850k was not just dumped on the market, it appear to have been worked in for someone. Hopefully, the volatile days are over. | elrico | |
19/1/2017 22:15 | was your sceptism ok? ;-) | fozdad | |
19/1/2017 22:14 | Couple of typos there: "To suggest otherwise is to propose...." And current not cittern positive indicators! | owenmo | |
19/1/2017 22:13 | You'll win even fewer posting twice ! Another positive day for the good ship Optibiotix. Building blocks being put in place. Hope those who were reviewing their positions by the end of the year didn't sell. | whl2 | |
19/1/2017 22:09 | I'll win few friends in proposing that this 200 DMA stuff is a crystal clear retrospective - changing daily on the back of market movement - only not directing it! Share-price movement creates the chart; the chart doesn't generate where the line may be headed. To suggest otherwise I'd to propose that tomorrow's buyers (if such there be) come on board by dint of where we're at on the moving average. Is it not more realistic that investors will buy-in on the back of cittern positive indicators - in turn bringing the moving average with them. Clearly I'm a chart sceptic but will own up to ignorance to go hand-in-hand with my sceptism. | owenmo | |
19/1/2017 22:08 | I'll win few friends in proposing that this 200 DMA stuff is a crystal clear retrospective - changing daily on the back of market movement - only not directing it! Share-price movement creates the chart; the chart doesn't generate where the line may be headed. To suggest otherwise I'd to propose that tomorrow's buyers (if such there be) come on board by dint of where we're at on the moving average. Is it not more realistic that investors will buy-in on the back of cittern positive indicators - in turn bringing the moving average with them. Clearly I'm a chart sceptic but will own up to ignorance to go hand-in-hand with my sceptism. | owenmo | |
19/1/2017 21:26 | It seems like this stock is changing to buying on the dips rather than selling the rallies. It feels like the worm has turned. | lodger | |
19/1/2017 20:19 | So we're now sat above the 200 day moving average: Very bullish if we have a weekly close around or above this level! | parob | |
19/1/2017 19:56 | Risky Good luck to them there's very little stock about it seems. Sm | shrewdmole | |
19/1/2017 19:38 | This is an interesting article. So weight may be modified by changing the ambient temperature? | maxwellsdemon | |
19/1/2017 19:08 | Have a feeling opti will start to see some long awaited ii's buying in on the back of recent appointments. Clearly signals transition from development phase which is usually too risky for ii's. £3m still in the bank and revenues on their way what a position to be in..Very surprised to hear sugars potentially available end of year/ early 2018. Serious company in the making. | riskybusiness1 | |
19/1/2017 18:52 | I wonder if that Friday only discount is to clear old stock because didn't someone mention they are repackaging the boxes for Go Figure? Hey.... Wouldn't it be fab if new wording said something about number one diet product? Mind you, I wonder if it's to print it in different languages the packaging... Perhaps those worldwide destinations ? Who knows, time will tell. | joyjoy13 | |
19/1/2017 18:44 | No....not selling! This is my nest egg, biggest investment I've ever had the confidence in because of ALL the strings to their bow! opportunities worldwide! But I did my research and continue to watch daily for news so I'm very happy with progress and can't wait for those seminars! Please do your own research folks, don't be swayed by my opinions. Good luck | joyjoy13 | |
19/1/2017 18:29 | re, 18958, you just might think of selling (some) if it spikes to over £1 one day (on a very good RNS), that will be a good test | neftanikoff | |
19/1/2017 17:28 | Well, I for one wont be selling any, I think the £1 from Zak Mir will be peanuts in the long term! Look how many divisions they are planing..., the potential is huge! Just wished I'd of bought more on the dips. DYOR good luck all | joyjoy13 | |
19/1/2017 17:23 | Sanguine :) | judijudi | |
19/1/2017 16:56 | Hi Elrico, yep I'd confident skinbiotic will be de-risked soon and proved successful. Just need further news and confirmation, but I'm sure its coming... :) | woodaldo | |
19/1/2017 16:38 | "Late stage discussions" way back in October was it not shrewdie? With any IPO there is bound to II participation, so no surprise there, otherwise it would be problematic getting the price OPTI have in mind. | elrico | |
19/1/2017 16:36 | Woodaldo - I would add skinbiotix as derisked also, otherwise why demerge? So, as you rightly point out, 3 divisions have been derisked and I would hope, expect the pending Finncap note would point these facts out. | elrico | |
19/1/2017 16:34 | I'd hazard a guess they are in discussions with early stage investment funds to take a decent stake in the skin subsidiary. | shrewdmole | |
19/1/2017 16:16 | We can't all have missed it, bit surprising not saying anything about it | neftanikoff | |
19/1/2017 16:13 | Woodaldo, agreed and I still believe we will see the anticipated demerger fairly soon. | rafboy | |
19/1/2017 16:10 | I think one of the things to take from that interview is further confirmation that the science works. For such a ground breaking science that this is, it wasn't long ago that we hoped that maybe just 2 of these product lines took off. Now we know the slimbiome works and its market share is going to grow, we know they are launching the cholesterol (optiscreen) product in spring, and now confirmation that sugar (optibiotics) was progressing well and likely to launch at the end of the year. So that's 3 divisions that look like delivering now or in the near future...All very promising. | woodaldo | |
19/1/2017 16:06 | I didn't hear him mention skin demerger. Slimbiome, then cholestrol, then potentially sugar, but no mention of skin this time. | lodger |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions